Geneva, May 7 (RHC)-- The World Health Organization's declaration that COVID-19 is no longer a global health emergency elicited fresh calls for learning from the pandemic and dramatically expanding access to prevention and treatment for diseases in the future.
"COVID-19 may no longer be classified as the highest level of international emergency, but the virus has not gone away," said Dr. Mohga Kamal-Yanni, policy co-lead of the People's Vaccine Alliance, a global coalition working toward equitable access to medical technologies that help to prevent and respond to Covid-19 and future pandemics.
"There are billions of people in developing countries who still cannot access affordable COVID-19 tests and treatments," Kamal-Yanni stressed. "They need action from governments to remove the intellectual property barriers that prevent the widespread production of generic medicines."
"Rich countries behaved shamefully in this pandemic, upholding pharmaceutical monopolies and grabbing vaccines, tests, and medicines for their people, pushing developing countries to the back in the line."
WHO Director-General Tedros Adhanom Ghebreyesus said Friday that while the agency has documented almost 7 million deaths from the virus, "we know the toll is several times higher—at least 20 million." A study published last year in Nature and cited by the People's Vaccine Alliance estimates that 1.3 million fewer people would have died by the end of 2021 if COVID-19 vaccines were equitably distributed.
"Rich countries behaved shamefully in this pandemic, upholding pharmaceutical monopolies and grabbing vaccines, tests, and medicines for their people, pushing developing countries to the back in the line," said Kamal-Yanni. "And pharmaceutical companies are the biggest winners, achieving the biggest profit from a single medical product in history, while people died without access."
Ahead of the WHO announcement but in the wake of the annual general meetings of Johnson & Johnson, Merck, Moderna, and Pfizer, Amnesty International health adviser Tamaryn Nelson on Thursday lamented that the pharmaceutical giants declined to "right their wrongs" by passing resolutions to facilitate the universal distribution of Covid-19 vaccines.
"For the past three years, those at the helm of Big Pharma companies have seen earnings soar, while people in low- and lower-middle-income countries are still struggling to access lifesaving medicines," Nelson noted. "While their efforts to speedily develop COVID-19 vaccines should be recognized, it's clear pharmaceutical companies have failed in their human rights responsibilities when it comes to ensuring equal access—and continue to do so. Why aren't investors holding them to account?"
"With reports that Pfizer and Moderna are considering quadrupling the price of each COVID-19 vaccine in some countries, only 25% of people in low-income countries are now fully vaccinated and millions are still waiting for the first dose," she continued, calling the allocation of the shots "one of the worst examples of global inequality to date."
According to Nelson, "It's time for investors to ensure these companies are making structural changes with immediate effect to ensure the world can withstand future pandemics collectively, without leaving anyone behind."
Kamal-Yanni argued that tackling future crises will require more actively involving people from lower-income nations. "The institutions set up to support developing countries, like COVAX and ACT-A, failed to involve developing countries in their creation or decision-making, and failed to deliver an equitable response," she said. "For future pandemics, preparation and response must be led by the Global South, instead of creating more global platforms dominated by donors."
"People in developing countries should never again wait for the 'good will' of rich countries, nor charitable actions of pharmaceutical companies," she asserted. "The world needs transformative commitments in the Pandemic Treaty and International Health Regulations to ensure knowledge and technology are shared, remove intellectual property barriers, and to support medical research and manufacturing in developing countries."
Negotiators aim to finalize a draft of the Pandemic Treaty for consideration by the 77th World Health Assembly in 2024. "Just as with HIV, the global response to COVID-19 failed the world's most vulnerable, prioritizing windfall profits ahead of public health," said Kamal-Yanni. "World leaders must now learn from the last three years, and make structural changes in global health. Or else, we are doomed to repeat the mistakes of this pandemic in the next."
Dr. Uché Blackstock, a former emergency medicine professor who works to end bias and racism in healthcare, tweeted Friday that "it's truly unfortunate that both domestically and globally, other than vaccines—which I'm truly grateful to science for—there have been no significant improvement/investments in our public health infrastructure to keep people and their communities safe."
